Direct oral anticoagulants in patients with atrial fibrillation and liver cirrhosis: a single-center experience

Kardiol Pol. 2021;79(7-8):864-866. doi: 10.33963/KP.a2021.0036. Epub 2021 Jun 14.
No abstract available

MeSH terms

  • Administration, Oral
  • Anticoagulants / therapeutic use
  • Atrial Fibrillation* / complications
  • Atrial Fibrillation* / drug therapy
  • Humans
  • Liver Cirrhosis / complications
  • Liver Cirrhosis / drug therapy
  • Stroke* / drug therapy
  • Warfarin / therapeutic use

Substances

  • Anticoagulants
  • Warfarin